Syngene International

SYNGENE

₹ 666.65

₹ 14.65

2.24%

Syngene International
Market Sentiment

Timeline	Returns	Volume
Daily	-	-
Weekly	-2.04%	29,68,208
Monthly	-8.93%	2,07,50,618

Syngene International
Performance

DATA

CHART

Timeline	Daily	Weekly	Monthly
SYNGENE	-	-2.04%	-8.93%
Index	-	-1.46%	-2.67%
Peer Avg.	-	-3.41%	-1.74%

*Avg of index constituents

Syngene International
Fundamentals

DATA

CHART

Timeline	PE	PB	EV/EBIDTA	ROE	ROCE	Div. Yield
SYNGENE	60.60	7.46	28.01	13.27	13.21	0.16
Index	35.44	5.98	16.81	16.99	18.41	1.19
Peer Avg.	0.00	0.00	0.00	0.00	0.00	0.00

*Avg of index constituents

Syngene International
Key Metrics

DATA

CHART

Metrics	Sales Growth	Profit Growth	ROE	ROCE
FY '21-22	19.29%	-2.35%	13.27	13.21
FY '20-21	8.45%	-1.82%	16.57	15.37
FY '19-20	10.20%	24.35%	20.21	19.59

Syngene International
Shareholding Pattern

Promoters : 70.41%

FII : 13.67%

DII : 4.43%

Public : 11.49%

Others : 0%

Syngene International
Profit & Loss

DATA

CHART

Metrics	Sales	Expenditure	EBITDA	PAT
FY '21-22	2,602.80	1,863.65	847.55	394.80
FY '20-21	2,181.85	1,529.65	735.50	404.30
FY '19-20	2,011.90	1,409.10	698.90	411.80

All values are in crores

Syngene International
Peer Comparison

DATA

CHART

Metrics	Sales	Expenditure	EBITDA	PAT
SYNGENE	2,602.80	1,863.65	847.55	394.80
SUMICHEM	3,064.09	2,461.94	633.51	428.64
GMRINFRA	2,319.89	1,271.06	1,228.55	-455.81

All values are in crores

Syngene International
Similar Stocks

Syngene International Share Price

Syngene International Limited is an integrated research, development and manufacturing service company operating in India. The company provides contract research and manufacturing services from lead generation to clinical supply to pharmaceutical and biotechnology companies worldwide. Its services include drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process research and development, current good manufacturing practice (cGMP) production, formulation and analytical development, and clinical development services. It offers SynVent, a therapeutic discovery and development platform for drug development projects. SynVent's portfolio spans categories and therapeutic areas from small molecule inhibitors to targeted protein stabilisation. It serves the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries.

Syngene International FAQs

How to Buy Syngene International Share?

To purchase Syngene International shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Syngene International (ticker symbol: syngene) on the trading platform provided by your broker and purchase the shares.

What's Syngene International share price today?

The stock price of Syngene International as of 10 May 2024 is ₹666.65

What is the Market Cap of Syngene International?

Market capitalisation represents the total market value of a company's outstanding shares. As of 10 May 2024, Syngene International (ticker symbol: syngene) has a market capitalisation of approximately ₹2,47,56,46,56,150.00

What is the PE and PB ratio of Syngene International?

Syngene International Ltd's price-to-book ratio as of 10 May 2024 is 7.4585795, reflecting the market's valuation compared to its asset value. As of 10 May 2024, the trailing twelve months P/E (price-to-earnings) ratio is 60.597836, indicating the market values the company at around ₹60.60 for every ₹1 of earnings

What is the 52 Week High and Low of Syngene International Share?

Syngene International Ltd (syngene) hit its 52-week high at ₹860.25, and its 52-week low at { ₹650.10}.